Bisphosphonate osteochemonecrosis (bis-phossy jaw): Is this phossy jaw of the 21st century?

被引:177
作者
Hellstein, JW
Marek, CL
机构
[1] Univ Iowa, Dept Oral Pathol, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA
[3] Univ Iowa, Dept Med, Iowa City, IA 52242 USA
关键词
D O I
10.1016/j.joms.2005.01.010
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose: Bisphosphonates are being implicated in a growing number of complications of the jaws. A number of terms are being applied to this phenomenon and perhaps the descriptive term bisphosphonate osteochemonecrosis has the most merit. But the eerie similarity of this 21st century disease process with the 19th century disease known as phossy jaw is striking. As the nomenclature continues to evolve, the term used in this article will be bis-phossy jaw. This article will explore historical and current aspects of these diseases. Although there may be other mitigating factors, such as oral health, chemotherapy history, immune status, Karnofsky performance status, or Kaplan-Feinstein index, bisphosphonates appear to be the necessary component in cases of bis-phossy jaw. Materials: This is primarily a review article on reported cases of bis-phossy jaw, with historical looks at phossy jaw and osteoradionecrosis. Our laboratory has reviewed 20 suspected cases of bis-phossy jaw and the typical histopathologic features of bis-phossy jaw are presented. Results: Descriptions of phossy jaw and current bis-phossy jaw cases are remarkably similar. Histopathologic features of bis-phossy jaw showed intact vascular channels, even in areas with acute inflammatory infiltrates and bacterial overgrowth. Non-vital bone fragments with reduced evidence of osteoclastic action were also noted. Conclusion: Bis-phossy jaw may have more of a bacterial cofactor risk than osteoradionecrosis, and though altered angiogenesis may yet prove to be a factor, avascularity does not appear to be a major cofactor. The historical disease phossy jaw appears to serve as a possible analogous disease for current research and treatment of bis-phossy jaw. Prevention and early identification of patients at risk should be of prime concern. (c) 2005 American Association of Oral and Maxillofacial Surgeons.
引用
收藏
页码:682 / 689
页数:8
相关论文
共 58 条
[1]  
Adams CO, 1940, ARCH PATHOL, V30, P1192
[2]  
Aronson S M, 1997, Med Health R I, V80, P315
[3]   New foundations in understanding osteonecrosis of the jaws [J].
Assael, LA .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 62 (02) :125-126
[4]   Safety and convenience of a 15-minute infusion zoledronic acid [J].
Berenson, J ;
Hirschberg, R .
ONCOLOGIST, 2004, 9 (03) :319-329
[5]  
BERNIER JL, 1944, ATLAS DENT ORAL PATH, P156
[6]  
Blum T, 1924, J AM DENT ASSOC, V11, P802
[7]  
Bouquot Jerry E, 2003, J Am Coll Dent, V70, P38
[8]  
Carter GD, 2003, AUST DENT J, V48, P268
[9]   Bisphosphonate infusions: patient preference, safety and clinic use [J].
Chern, B ;
Joseph, D ;
Joshua, D ;
Pittman, K ;
Richardson, G ;
Schou, M ;
Lowe, S ;
Copeman, M ;
De Abreu Lourenco, R ;
Lynch, K .
SUPPORTIVE CARE IN CANCER, 2004, 12 (06) :463-466
[10]  
CLARK C, 1997, RADIUM GIRLS, P65